A Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer
Clinical trial NCT06472531 · COMPLETED
Trial details
- NCT number
- NCT06472531
- Sponsor
- Yunhe Pharmaceutical (Tianjin) Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-23
- Primary completion
- 2024-09-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.